|
1
|
SV Health Investors
Boston,
Massachusetts
|
$19.9M
|
–
|
–
|
–
|
|
|
2
|
Eventide Asset Management
Boston,
Massachusetts
|
$19.5M
|
+$2.91M
|
+180,000
|
+12%
|
|
|
3
|
Polar Capital
London,
United Kingdom
|
$16.3M
|
+$262K
|
+16,235
|
+1%
|
|
|
4
|
Fidelity Investments
Boston,
Massachusetts
|
$10.7M
|
-$833K
|
-51,535
|
-5%
|
|
|
5
|
Deerfield Management
New York
|
$10.3M
|
-$5.28M
|
-327,000
|
-27%
|
|
|
6
|
|
$8.89M
|
+$480K
|
+29,730
|
+4%
|
|
|
7
|
Adage Capital Partners
Boston,
Massachusetts
|
$8.12M
|
–
|
–
|
–
|
|
|
8
|
VHCP Management III
New York
|
$7.4M
|
–
|
–
|
–
|
|
|
9
|
Pictet Asset Management (UK)
London,
United Kingdom
|
$6.33M
|
+$1.47M
|
+90,989
|
+20%
|
|
|
10
|
Vanguard Group
Malvern,
Pennsylvania
|
$6.31M
|
+$262K
|
+16,219
|
+3%
|
|
|
11
|
InterWest Venture Management
San Francisco,
California
|
$4.51M
|
–
|
–
|
–
|
|
|
12
|
VHCP Management II
New York
|
$4.37M
|
–
|
–
|
–
|
|
|
13
|
Ghost Tree Capital
New York
|
$3.65M
|
+$242K
|
+15,000
|
+5%
|
|
|
14
|
State Street
Boston,
Massachusetts
|
$2.65M
|
+$441K
|
+27,325
|
+14%
|
|
|
15
|
Boxer Capital
San Diego,
California
|
$2.32M
|
–
|
–
|
–
|
|
|
16
|
Northern Trust
Chicago,
Illinois
|
$2.07M
|
+$1.69M
|
+104,691
|
+142%
|
|
|
17
|
International Biotechnology Trust
London,
United Kingdom
|
$2.06M
|
-$164K
|
-10,166
|
-5%
|
|
|
18
|
Geode Capital Management
Boston,
Massachusetts
|
$1.76M
|
+$160K
|
+9,912
|
+7%
|
|
|
19
|
Dimensional Fund Advisors
Austin,
Texas
|
$1.49M
|
+$272K
|
+16,860
|
+15%
|
|
|
20
|
|
$1.44M
|
+$851K
|
+52,643
|
+74%
|
|
|
21
|
Samsara BioCapital
Palo Alto,
California
|
$1.38M
|
–
|
–
|
–
|
|
|
22
|
Point72 Asset Management
Stamford,
Connecticut
|
$1.01M
|
-$1.23M
|
-75,900
|
-47%
|
|
|
23
|
Neuberger Berman Group
New York
|
$682K
|
-$90.3K
|
-5,588
|
-9%
|
|
|
24
|
Weiss Multi-Strategy Advisers
New York
|
$626K
|
–
|
–
|
–
|
|
|
25
|
|
$546K
|
+$423K
|
+26,181
|
+125%
|
|
